RAP 0.00% 20.5¢ resapp health limited

Quarterly will disappoint, to undermine the mgt's TO excitement...

  1. 2,872 Posts.
    lightbulb Created with Sketch. 285
    Quarterly will disappoint, to undermine the mgt's TO excitement at 11.5c ;-)

    dont know if mgt is really able to play this strategic game with/against a billion dollar company like pfizer. Think back at the first US Trial how they handled it. ;-)

    market is pricing in the TO as a done deal. The more turnover the more shares will shift into the "yes" camp.

    like usual in such situation the days before such an importent event the HC excitement is stellar and wishful thinking and finally proven wrong.

    IMO & perception
    Last edited by ravanelli77: 17/04/22
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.